Utah Medical Products
UTMD
59 hedge funds and large institutions have $138M invested in Utah Medical Products in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 58 → 59 (+1)
4% more capital invested
Capital invested by funds: $133M → $138M (+$4.95M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
+$1.74M |
| 2 |
Natixis Advisors
Boston,
Massachusetts
|
+$433K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$286K |
| 4 |
Renaissance Technologies
New York
|
+$267K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$262K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bares Capital Management
Austin,
Texas
|
-$383K |
| 2 |
AI
Analytic Investors
Los Angeles,
California
|
-$246K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$138K |
| 4 |
STC
SEI Trust Company
Oaks,
Pennsylvania
|
-$72.7K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$65.2K |
UTMD Hedge Fund Activity: Q1 2014 in Review
59 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2014, worth a combined $138M — up 3.7% from $133M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new UTMD positions and 3 closed out — a net gain of 1 holder — while 26 added to existing stakes and 13 trimmed.
The largest buyer was Morgan Dempsey Capital Management, adding an estimated $1.74M. The largest seller was Bares Capital Management, cutting an estimated $383K.
- 59 institutional investors held Utah Medical Products (UTMD) as of Q1 2014, up from 58 in Q4 2013.
- Funds reported $138M of Utah Medical Products stock for Q1 2014, up 3.7% quarter-over-quarter.
- 4 funds opened new Utah Medical Products positions in Q1 2014 and 3 closed out, a net change of +1 holder.
- The largest Utah Medical Products buyer in Q1 2014 was Morgan Dempsey Capital Management, an estimated $1.74M added.
- The largest Utah Medical Products seller in Q1 2014 was Bares Capital Management, an estimated $383K sold.
Based on aggregated 13F filings for Q1 2014.